Le Lézard
Classified in: Health
Subject: CCA

Neovasc to Host Third Quarter 2017 Conference Call


VANCOUVER, Nov. 10, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that it will release its financial results for the third quarter 2017 on Tuesday, November 14, 2017, after markets close. The Company will subsequently hold a conference call that same day at 4:30 pm Eastern Time hosted by Mr. Alexei Marko, Chief Executive Officer, and Mr. Chris Clark, Chief Financial Officer. A question and answer session will follow the corporate update.

Conference Call Details


Tuesday, November 14, 2017


4:30 pm ET


888 390 0605 or 416 764 8609


A link to the live audio webcast of the conference call will also be available on the Presentations and Events page of the Investors section of Neovasc's website at www.neovasc.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to hear the webcast.  

A recording of the call will be available for 72 hours by calling 888 390 0541 or 416 764 8677 and using passcode 762334#.

About Neovasc Inc. 
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.  Its products include the Neovasc Reducertm, for the treatment of refractory angina which is not currently available in the United States and has been available in Europe since 2015 and the Tiaratm, for the transcatheter treatment of mitral valve disease, which is currently under investigation in the United States, Canada and Europe. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.

SOURCE Neovasc Inc.

These press releases may also interest you

at 11:02
Akoya Biosciences, a private biotech start-up, announced today that VIB, a leading life sciences institute in Belgium, will be one of its first partners for exploring the CODEXtm (CO-Detection by indexing) technology in Europe. The CODEXtm technology...

at 11:00
Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids. Published in the journal Cell Stem Cell the study is...

at 11:00
London's hospitals and patients will not escape the impact of cutbacks resulting from the combination of 4 per cent spending cuts, $7 billion in tax cuts and a drive for a balanced budget ? all promised by Ontario's PCs, warns the Ontario Council of...

at 11:00
People with deep-vein thrombosis (DVT) can substantially cut their risk of potentially debilitating complications by starting adequate compression therapy in the first twenty-four hours of DVT therapy (known as the acute phase of treatment), suggests...

at 11:00
On September 18, 2018, mediator/arbitrator William Kaplan issued an award that establishes a collective agreement for more than 3,000 employees in the Health Administrative Professional Bargaining Unit at the NSHA and the IWK....

at 11:00
Tuesday's Children, the leading nonprofit organization providing long-term support to communities, families and individuals impacted by terrorism or the loss of a service member in the military, has added financial and operational executives Patrick...

News published on 10 november 2017 at 14:56 and distributed by: